The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Sprague, Stuart
One or more keywords matched the following items that are connected to Sprague, Stuart
Item TypeName
Concept Phosphorus
Concept Phosphorus, Dietary
Academic Article Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.
Academic Article The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
Academic Article Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
Academic Article Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
Academic Article Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.
Academic Article Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.
Academic Article Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study.
Academic Article Abnormal bone and mineral metabolism in kidney transplant patients--a review.
Academic Article Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
Academic Article Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl.
Academic Article Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Academic Article Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.
Academic Article Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
Academic Article Women and CKD-mineral and bone disorder.
Academic Article A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients.
Academic Article Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
Academic Article Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Academic Article Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
Academic Article Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data?.
Academic Article Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Academic Article Secondary Hyperparathyroidism in a Patient with CKD.
Academic Article Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.
Academic Article Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence.
Academic Article Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis.
Search Criteria
  • Phosphorus